A world leading expert on cholestatic itch, Professor Kremer shed light on the underlying mechanisms and potential therapeutic strategies that could significantly improve treatment options for patients suffering from this debilitating symptom in cholestatic liver diseases.
The Research Council's commercialisation support is intended to contribute to the use of publicly funded research through increased commercial exploitation and/or societal innovation. Researchers from NoPSC will now be able to test the commercialization potential of the DUCT chip.
The official opening of the new ERC Consolidator Grant project «FatVersusBile» was celebrated at the Institute for Internal Medicine Monday May 6th.
Professor Tom Hemming Karlsen recieved the prestigues 2025 Max Siurala Award.
